FOLLOW US

Thyroid Disorders Research Updates

For Medical Professionals

A new study re-examines the cancer risk associated with radioactive iodine treatment.
Thyroid cancer trial halted for lack of efficacy while best benign nodule treatment clarified
Serum thyroid stimulating hormone autoantibodies (TSAbs) levels are sensitive and specific biomarkers for the diagnosis of Graves’ disease in childhood.
The FDA announced approval of Nexavar® tablets (sorafenib) for the treatment of patients with locally recurrent or metastatic, progressive, differentiated thyroid carcinoma that is refractory to radioactive iodine treatment.
Researchers examined whether thyroid cancer patients treated with radioactive iodine experienced a reduction in swallowing-related quality of life. Read their results.
Researchers examined the correlation between hyperthyroidism and atrial fibrillation in patients admitted to the hospital with new-onset AF.
close X
SHOW MAIN MENU
SHOW SUB MENU